Trials / Completed
CompletedNCT00441051
Efficacy and Safety of Diclofenac Sodium (0.1%) Gel in Patients With UV Induced Painful Sunburn
A Randomized, Double-Blind, Vehicle-Controlled, Single Center, Intra-Individual Comparative Study of the Efficacy and Safety of Diclofenac Sodium 1 mg/g (0.1%) Gel in Subjects With Painful UV-Induced Erythema
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 45 (planned)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Diclofenac sodium 0.1% will be applied to sunburned skin when the intensity of pain reaches a certain level in order to evaluate the efficacy and safety of the treatment on this induced pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diclofenac sodium 1mg/g |
Timeline
- Start date
- 2006-11-01
- Completion
- 2006-12-01
- First posted
- 2007-02-28
- Last updated
- 2007-02-28
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00441051. Inclusion in this directory is not an endorsement.